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Identifying the downstream targets of microRNAs (miRNAs) is
essential to understanding cellular regulatory networks. We de-
vised a direct biochemical method for miRNA target discovery that
combined RNA-induced silencing complex (RISC) purification with
microarray analysis of bound mRNAs. Because targets of miR-124a
have been analyzed, we chose it as our model. We honed our
approach both by examining the determinants of stable binding
between RISC and synthetic target RNAs in vitro and by determin-
ing the dependency of both repression and RISC coimmunopre-
cipitation on miR-124a seed sites in two of its well characterized
targets in vivo. Examining the complete spectrum of miR-124
targets in 293 cells yielded both a set that were down-regulated at
the mRNA level, as previously observed, and a set whose mRNA
levels were unaffected by miR-124a. Reporter assays validated
both classes, extending the spectrum of mRNA targets that can be
experimentally linked to the miRNA pathway.
gene regulation  RNAi  RISC  immunoprecipitation
M icroRNAs (miRNAs) are a widely distributed class ofnoncoding RNAs that play an integral role in gene regu-
lation (1). Hundreds of microRNA species have been discovered
in animals and plants, many of which exhibit temporally and
spatially controlled expression. While the list is rapidly growing,
clear examples of microRNA function have been shown in
development, differentiation, proliferation, apoptosis, metabo-
lism, and tumor initiation and progression (reviewed in ref. 2).
Mature miRNAs function in stable complexes with proteins of
the Argonaute family, the core of the RNA-induced silencing
complex (RISC) (3, 4). In animals, the 21- to 22-nt miRNA
targets RISC tomRNAs with partial sequence complementarity.
By using this f lexible recognition mechanism, an average
miRNA is estimated to affect expression of hundreds of mRNAs.
The RISC–mRNA interaction results in translational repression
that may also be accompanied by mRNA destruction (5–9).
However, the precise factors that determine the extent to which
mRNA decay versus translational repression contributes to
silencing are not currently well understood.
A basic set of rules governing the recognition of the target by
the miRNA has emerged from natural and artificial miRNA-
target pairs. Complementarity to the target message in the 5
region of the miRNA, particularly nucleotides 2–8 (the ‘‘seed’’
region), is the strongest indicator of functional interaction (1).
However, extensive complementarity at the 3 end of themiRNA
can compensate for a nonideal seed interaction (10). Addition-
ally, the sequence context outside of the miRNA binding site can
impact regulation (11). Endogenous miRNA targets often have
multiple complementary sites, and artificial constructs have
shown that the presence of several sites improves regulation (12).
Finally, synergistic activity of multiple miRNAs on the same
mRNA has been demonstrated using reporters and has been
postulated for endogenous targets (13, 14).
Steady progress is being made in genetically probing the
functions of miRNAs themselves. However, identifying the
targets that mediate such functions has provenmore challenging.
Currently, two approaches are widely used. One relies on
measuring reductions in target mRNA levels caused by an
exogenously added miRNA (15). In the seminal study, 174 and
96 potential targets of miR-124a and miR-1, respectively, were
identified by miRNA delivery to HeLa cells. With this approach,
targets whose stability is not affected appear as false negatives,
and mRNAs that are down-regulated through secondary effects
score as false positives. Multiple computer prediction algorithms
have also been developed that use established miRNA–mRNA
interaction rules, some of which have been trained on existing
microarray data, to identify miRNA targets (16–19). To maxi-
mize their fidelity, the current methods require a fully comple-
mentary seed sequence in the 3 UTR and conservation of the
site across several species, thus potentially missing targets that do
not conform to these rules. In both cases, potential targets are
typically validated by using luciferase sensors containing the
target 3 UTR.
Results
Ago2 Coimmunoprecipitates mRNA Targets.A detailed understand-
ing of the biological function of any miRNA requires the
identification of its direct mRNA targets. We sought to develop
a biochemical method to isolate such targets, hypothesizing that
an Ago2-coimmunoprecipitation approach might retain mRNAs
containing miRNA binding sites. We initially combined bio-
chemical systems, which we had previously used to study RISC
effector mechanisms, with well established, artificial reporters of
microRNA-mediated repression. 293S cells stably expressing
c-myc-tagged Ago2 were transfected with either a let-7 siRNA or
a control siRNA against firefly luciferase (GL3.1) and used to
prepare extracts. In vitro-transcribed let-7 targets were prepared
that contained zero, one or three bulged (miRNA-like) let-7 sites
(9). These targets were incubated with lysates, and RISC was
recovered by immunoprecipitation with anti-c-myc beads (Fig.
1A). Strikingly, c-myc-Ago2 programmed with let-7 was able to
coimmunoprecipitate target RNAs containing three let-7 sites,
but not the control RNA or the RNA with only a single site.
Control extracts containing GL3.1-programmed RISC or let-7
programmed RISC that lacked a c-myc tag did not permit
recovery of synthetic targets in immunoprecipitates (IPs). In
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similar studies, Ago1 performed analogously to Ago2 [support-
ing information (SI) Fig. 6]. Thus, retention of targets by RISC
was observed in a miRNA- and binding site-dependent manner.
Building upon these in vitro results, we assessed the ability of
RISC to retain endogenousmiRNA targets. miR-124a served as an
attractive model because of the availability of a large set of
experimentally determined target candidates (15). Because miR-
124a is absent in 293S cells, we were able to compare retention of
specific mRNAs by miR-124a-programmed and unprogrammed
RISC. Both total mRNAs and c-myc coimmunoprecipitated
mRNAs from miR-124a- or GL3.1-transfected cells were analyzed
by reverse transcription followed by quantitative PCR (RT-QPCR)
using primers for several targets, including Ctdsp1/SCP1, Plod3,
and Vamp3 (20, 21). Results were quantified as enrichment or
depletion in the miR-124a sample relative to the GL3.1 control
(Fig. 1B). Because no mRNA can be conclusively declared a
non-target a priori, the QPCR data were not normalized to a
particular control gene but rather were contrasted with a panel of
housekeeping genes that were unlikely, in aggregate, to be miR-
124a targets (14).
As previously reported, depletion of Ctdsp1, Plod3, and
Vamp3 mRNAs in miR-124a-transfected cells was observed in
total mRNA (Fig. 1B). Despite these reduced mRNA levels, all
three targets were significantly enriched in the immunoprecipi-
tates. Dividing the enrichment in the IP by the change in total
mRNA level gave a Net IP enrichment (see below) of 7.6- to
38-fold for the targets, compared with 0.8- to 1.1-fold for
housekeeping mRNAs (Fig. 1B). Thus, RISC programmed with
miR-124a robustly and specifically coimmunoprecipitates en-
dogenous mRNA targets.
miR-124a Seed Sites in the 3 UTRs of Vamp3 and Ctdsp1 Are Required
for Regulation and Coimmunoprecipitation. If mRNA retention on
RISC related to microRNA-mediated regulation, it should depend
upon miR-124a binding sites in the mRNA. To investigate the role
of 3 UTR seed matches in RISC association and regulation for
direct targets, we created a series of seed site deletions in luciferase
reporters bearing the UTRs of Ctdsp1 and Vamp3. When the
Vamp3 reporter was tested in cortical neurons in the presence of
endogenous miR-124a, a loss of repression was observed in con-
structs lacking miR-124a seed complementary sites (Fig. 2A). The
seed sites seemed to act in a roughly additive manner, with the full
set of sites necessary for complete regulation. A similar dependence
of regulation on seed sites was observed when the reporters were
tested inmouse kidney cells (TCMK1; Fig. 2B), or 293S(Ago2) cells
transfected with miR-124a (SI Fig. 7). Importantly, both reporters
showed the same dependency on seed sites when assayed for their
association with RISC by coimmunoprecipitation (Fig. 2C), where
a complete deletion of 7-mer seed sites reduced mRNA-RISC
interactions to basal levels. We conclude that the predicted miR-
124a binding sites in the 3 UTRs of Ctdsp1 and Vamp3 are
necessary both for regulation by miR-124a and for physical asso-
ciation with miR-124a-programmed Ago2.
Transcriptome-Wide Identification of miR-124a Targets.To identify a
comprehensive set of miR-124a targets, we used Ago2 coimmu-
noprecipitation followed by microarray hybridization. In paral-
lel, total mRNA levels from the same samples were also mea-
sured on microarrays. For each mRNA, we envisioned a number
of possible behaviors in the microarray studies. For all mRNAs,
we expected the amount immunoprecipitated with Ago2, both
for biologically relevant retention and for nonrelevant interac-
tions, to depend, in part, on the starting levels of the mRNA. For
non-target mRNAs (representing the majority of probes on the
array), the immunoprecipitated amount would simply be pro-
portional to mRNA levels in the miR-124a and control samples,
as retention would be caused only by nonspecific association.
Accordingly, an overall positive correlation between abundance
in total mRNA and IP samples was observed (average correla-
tion coefficient 0.81). In contrast, bona fide miRNA targets were
predicted to show greater retention by Ago2, which would be
superimposed on this basal trend.
Thus, for each mRNA, the change in overall abundance in the
total mRNA sample was determined by comparison of miR-124a
and GL3.1 control samples. The subset in which mRNA levels
decreased specifically in the presence of miR-124a was defined
as the Down-regulated set. Raw enrichment in the Ago2 IP (Raw
IP enrichment) was also determined, and the ratio of these values
yielded a Net IP enrichment that incorporated both mRNA
abundance changes and specific binding to Ago2.
This analysis identified 126 probes that, upon miR-124a
transfection, were significantly reduced (adj. P 0.0001) in total
mRNA (Down-regulated set; Fig. 3 Inset A, blue) and 550 probes
that showed significant Raw IP enrichment in RISC (red), with
little overlap (white) between the two sets. Calculating the Net
IP enrichment identified 370 probes that showed miR-124a-
dependent association with Ago2 (Fig. 3 Inset B, green), with
substantial overlap between those mRNAs that showed Raw IP
enrichment and those in the down-regulated set (Fig. 3, colored
to show the overlap). The converse analysis, looking for probes
with Net IP enrichment in RISC immunoprecipitated from the
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Fig. 1. Programmed Ago2 coimmunoprecipitates miRNA targets. (A) Lysates
from 293S or 293S(c-myc-Ago2) cells transfected with let-7 or GL3.1 siRNAs
were incubated with radiolabeled RNAs containing zero, one or three let-7
binding sites, and immunoprecipitated with anti-c-myc beads. T, total lysate
(1/10 of immunoprecipitated volume); I, immunoprecipitated complexes. (B)
Retention of endogenous miR-124a targets. 293S(Ago2) cells were transfected
with miR-124a or GL3.1 siRNAs, lysed, and immunoprecipitated. Transcript
levels in total and immunoprecipitated fractions were quantified by RT-QPCR.
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GL3.1 control samples, identified only 105 probes (Fig. 3 Inset B,
black), likely representing ‘‘off-targets’’ for the synthetic GL3.1
siRNA. For the identified probe sets, see SI Dataset 1.
Thus, coimmunoprecipitation with Ago2 and decrease in total
mRNA levels identified distinct, but overlapping, sets of possible
miR-124a targets. The effectiveness and scope of these ap-
proaches was initially evaluated by searching the 3 UTRs of the
identified gene sets and their overlapping subsets for the pres-
ence of miR-124a 7-mer seed matches (Table 1). In agreement
with previous studies (15), 109 genes corresponding to the 126
probes that show mRNA reduction upon miR-124a delivery
(Down-regulated set; Fig. 3, blue, cyan, and white) were signif-
icantly enriched in 7-mer seed sites (0.56 sites per kilobase). The
set identified by Raw IP enrichment (red, yellow, and white) also
had a high prevalence of seeds (0.40 sites per kilobase). The
magnitude of this signal was likely reduced by probes that were
also up-regulated in total mRNA and were retained by nonspe-
cific interactions (Fig. 3, red, 0.26 sites per kilobase). Impor-
tantly, the gene set showing Net IP enrichment (cyan, green,
yellow, and white) showed an overall seed signal (0.55 sites per
kilobase) similar to the Down-regulated set. Strikingly, the Net
IP enrichment set overlapped with the Down-regulated gene set
by only 63 genes (Fig. 3, cyan and white), and included an
additional 231 genes that could not be identified solely by
monitoring changes in mRNA levels. Importantly, this final class
still exhibited a significant enrichment for seed sites (0.48 sites
per kilobase; green and yellow). This large set of candidate
miR-124 targets may represent those where regulation occurs
primarily by translational repression without changes in mRNA
stability (22).
Within the set of mRNAs down-regulated by miR-124a, those
that were also in the Net IP enrichment set (cyan and white)
showed a dramatically higher frequency of seed sites (0.81 sites
per kilobase) than those that were not identified by Net IP
enrichment (blue, 0.24 sites per kilobase). The blue set may
represent genes that are down-regulated as an indirect conse-
quence of miR-124a action. Thus, scoring for Net IP enrichment
likely enhances the identification of bona fide miR-124a targets
that are down-regulated in total mRNA.
Most Immunoprecipitated mRNAs Are Direct miR-124a Targets. To
probe the utility and specificity of the biochemical approach to
target identification, we set out to validate a subset of the
identified target candidates. We focused on the class of targets
that did not change in total mRNA levels, as these genes would
not be identified by existing experimental methods. Four genes
identified by Net IP enrichment that were also in the Down-
regulated set and 30 genes that were not significantly decreased
in total mRNA, but identified by Raw IP enrichment, were
randomly chosen. The 3 UTR from each candidate was cloned
into a firef ly luciferase reporter plasmid and assayed in
293S(hAgo2) cells for response to transfectedmiR-124a. All four
genes from the Net IP enrichment and Down-regulated sets, and
21 of 30 genes from the Raw IP enrichment set (but not
Down-regulated) showed statistically significant regulation by
miR-124a compared with a GFP siRNA control (P  0.05,
Student’s t test) (Fig. 4).
A Subset of miR-124a-Down-RegulatedmRNAs Are Direct Targets.For
comparison with targets identified by direct biochemical meth-
ods, we used an independent experimental strategy to identify
direct miR-124a targets in a previously published dataset. Mouse
orthologs of the 174 candidate targets identified by Lim et al. (15)
were interrogated in a series of assays: (i) down-regulation of the
mRNA in mouse embryonic fibroblasts (MEFs) upon ectopic
delivery of miR-124a, (ii) up-regulation of the mRNA in primary
cortical neurons (CNs) upon inhibition of miR-124a with a
2-O-methyl antisense oligonucleotide, and (iii) up-regulation of
luciferase reporters bearing the 3 UTR of the putative targets
in CNs upon miR-124a inhibition (SI Fig. 8). Filtering the set
based on the aforementioned assays identified a set of 22 genes
that scored positively in all three tests, strongly suggesting that
these genes were direct targets of miR-124a. Additionally, 62
genes that scored in assay 1 plus either assay 2 or assay 3 were
classed as potential targets (SI Table 2). Forty-eight genes scored
only in assay 1. These genes were classed as likely secondary or
nonspecific targets as they do not show a response to endogenous
miR-124a in a relevant cell type. Importantly, the 3 UTRs of
direct miR-124a targets contained significantly more 6-mer
(positions 1–6 and 2–7 of miR-124a) and 7-mer seed matches
than the potential targets, which were only slightly enriched
compared with the nonspecific targets (Fig. 5A).
To correlate these validated target sets with our biochemically
identified targets, we analyzed the net IP enrichment of human
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Fig. 2. Seed sites in the 3 UTRs of Vamp3 and Ctdsp1 are important for
miR-124a regulation and Ago2-coimmunoprecipitation. (A) Luciferase activity
of sensor constructs bearing the Vamp3 3UTR with sequential seed site
deletions transfected into primary cortical neurons together with the RL
expression vector. (B) Sensor constructs containing the Vamp3 and Ctdsp1 3
UTRs with sequential deletions of the seed sequences were transfected into
mouse kidney cells (TCMK1) together with either an expression vector for
miR-124a or pcDNA and a vector expressing Renilla luciferase (RL). (C) Sensor
constructs containing the Vamp3 and Ctdsp1 3 UTRs, wild-type or lacking
7-mer seed sites were transfected into 293S(Ago2) cells along with miR-124a
or GL3.1 siRNAs. Transcript levels in Ago2-coimmunoprecipitates were mea-
sured by RT-QPCR. Error bars represent standard deviation of three indepen-
dent experiments (*, P  0.05; **, P  0.005; Student’s t test).
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orthologs of each gene set (Fig. 5B). The direct targets showed
a markedly stronger Net IP enrichment with a mean fold change
of 3.42. The potential target set was moderately enriched in the
Net IP set (mean fold enrichment 2.58), and the non-targets
showed the least Net IP enrichment (2.12-fold). This higher Net
IP enrichment of direct targets reflected a combination of a
somewhat stronger down-regulation in total mRNA (SI Fig. 9A)
and a more pronounced enrichment in RISC immunoprecipi-
tations (SI Fig. 9B). Therefore, Net IP enrichment of mRNAs in
purified RISC preferentially identifies the direct targets of
miR-124a, even though the experiment was performed in a
model cell line.
Global Enrichment of miRNA Targets. The immunoprecipitated
RISC has the potential to contain the entire set of endogenously
expressed miRNAs and their targets, not only targets of the
transfected miR-124a or GL3.1. Because the targets of other
microRNAs are found in RISC populations from cells trans-
fected with both miR-124a and GL3.1, they would not be
detected in the aforementioned analysis. To examine the possi-
bility that endogenous miRNA targets might be recovered, we
looked for overall enrichment of mRNAs in the IP as compared
with total RNA, considering the miR-124a and GL3.1 samples
together. This analysis identified 2,941 probes at a P value cutoff
of 0.0001, which are related to 2,578 genes. Next, we considered
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Table 1. Enrichment of miR-124a seed sites in 3’ UTRs of gene sets identified by microarray analysis
Gene sets No. of genes No. of sites Total 3’ UTR length Sites per kilobase
Down-regulated 109 71 126,051 0.5633
Raw IP 432 199 500,926 0.3973
Net IP 294 196 359,409 0.5453
Subsets
In Down-regulated only (blue) 46 13 54,088 0.2403
In Raw IP only (red) 238 70 271,892 0.2575
In Net IP only (green) 60 37 83,437 0.4434
In Down-regulated and Net IP only (cyan) 40 30 46,938 0.6391
In Raw and Net IP only (yellow) 171 101 204,009 0.4951
In Down-regulated, Raw, and Net IP (white) 23 28 25,025 1.1189
In Net IP, but not Down-regulated (green and
yellow)
231 138 287,446 0.4801
In Net IP and Down-regulated (cyan and white) 63 58 71,963 0.8060
All other genes (background) 21,948 2,312 26,445,994 0.087
Genes passing a P  0.0001 cutoff for which a 3’ UTR sequence could be obtained from public databases were analyzed.
19294  www.pnas.orgcgidoi10.1073pnas.0709971104 Karginov et al.
hexamer seed density in the 3 UTRs of these mRNAs, com-
paring it with density in the 3UTRs of a background set of genes
that were not enriched in the IP. The seed density distribution
for the 25 most abundant Ago2-associated miRNAs in 293T cells
(23) was shifted toward the IP-enrichedmRNAs, i.e., those seeds
were more abundant in IP-enriched mRNAs. The distribution
was significantly different from the density distribution of all
possible hexamers between the two gene sets [P value  0.002;
Kolmogorov-Smirnov (KS) test]. Such a detectable shift is
notable, considering that within the 2,578 IP-enriched genes, a
given endogenous miRNA would be expected to have only tens
to hundreds of targets contributing to its hexamer site enrich-
ment. These observations raise the possibility that antagomir
strategies might be used to identify miRNA targets in directly
relevant cell types by their depletion from Ago2 IPs upon
microRNA inhibition.
Discussion
We present a method for comprehensive miRNA target iden-
tification by coimmunoprecipitation of messenger RNAs with
miRNA-programmed Ago2 and show that this approach reca-
pitulates the major characteristics of known miRNA–target
interactions. Many natural and artificial targets, including the
let-7 constructs used in this study (9), require multiple miRNA
binding sites for efficient regulation. Accordingly, three let-7
sites were required for coimmunoprecipitation of artificial tar-
gets with Ago2, whereas a single site was insufficient. In natural
targets of miR-124a, single sites, evolutionarily selected for their
regulatory capacity, were often sufficient for retention. Impor-
tantly, in the cases where naturally functioning miR-124a
miRNA binding sites have been mapped by mutagenesis (Ctdsp1
and Vamp3), the same sites were necessary both for repression
of luciferase reporters and for retention by Ago2. The genes
identified by coimmunoprecipitation with miR-124a-
programmed Ago2 are significantly enriched in miR-124a seed
complements in their 3 UTRs, consistent with the notion that
seed sites are strong first-order indicators of a miRNA–mRNA
interaction.
Overall, Net IP enrichment is a highly specific and compre-
hensive predictor of consequential miRNA–mRNA interactions.
This is likely the case for several reasons. First, the Down-
regulated set contains both direct targets and mRNAs, whose
abundance drops as a secondary consequence of miRNA action.
The latter would not be enriched in the IP, thus distinguishing
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them from primary targets. The IP set contains not only bona
fide targets but also those, which associate nonspecifically or
bind Ago as a consequence of their interaction with an endog-
enous microRNA. Such mRNAs that are not miR-124a targets
but that increase in abundance as a secondary consequence of
miR-124a transfection would seem to be enriched in the IP.
These mRNAs would score as false-positives in the Raw IP
enrichment set. Therefore, taking into account both changes in
abundance and IP retention focuses attention on the true target
set. Importantly, the Ago IP identifies a large class of potential
targets that are not decreased at the mRNA level and that would,
therefore, be missed using current experimental approaches to
target identification. For miR-124a, the set of targets identified
through the procedures outlined here was 3-times as large as
that identified by down-regulation alone.
A biochemical method for identifying microRNA targets
holds the promise of deepening our understanding of the
determinants of microRNA-mediated regulation, particularly by
revealing targets that are repressed without changes in mRNA
levels. Identification of this class of targets will provide an
opportunity to glean sequence or structural features of these
mRNAs that determine their regulatory fate. In this respect, a
recent study by Sharp and coworkers (22) probed groups of
mutations affecting the miRNA-target duplex that destine the
reporter for mRNA degradation, translational repression, or a
combination of both. The method described herein also provides
an important balance to in silico methods of predicting mi-
croRNA targets, which, while growing in power, still fail to
provide a complete and wholly precise picture of miRNA
regulatory networks.
Materials and Methods
Coimmunoprecipitation with Ago2 and Analysis of Targets. Where
indicated, 293S(Ago2) or the parental 293S cells were trans-
fected with the appropriate plasmid constructs. Cells were
harvested 48 h after transfection and washed in PBS followed by
hypotonic lysis buffer [10 mM Tris, pH 7.5, 10 mM KCl, 2 mM
MgCl2, 5 mMDTT, and 1 tablet per 10 ml of protease inhibitors,
EDTA-free (Roche)]. Cells were incubated in lysis buffer for 15
min and lysed by douncing. Immediately after douncing, the
lysates were supplemented with 5 ATP depletion mix [4
units/l RNaseIn (Promega), 100 mM glucose, 0.5 units/l
hexokinase (Sigma), 1 mg/ml yeast tRNA (Invitrogen), 450 mM
KCl] to a final concentration of 1. The lysates were cleared by
centrifugation at 16,000  g for 30 min at 4°C. Capped and
radiolabeled let-7 targets were incubated with lysates at 30°C for
1 h at this stage. Aliquots of total RNA (1/10 for radiolabeled
samples and 1/20 for other) were taken and extracted with
TRIzol. Before immunoprecipitation, anti-cmyc beads (Sigma)
were preblocked for 30 min in wash buffer [0.5% Nonidet P-40,
150 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 20 mM Tris, pH 7.5,
5 mM DTT, and 1 tablet per 10 ml of protease inhibitors,
EDTA-free (Roche)] supplemented with 1 mg/ml yeast tRNA
and 1mg/ml BSA, followed by a wash in wash buffer. One volume
of wash buffer was added to the lysates, and cmyc-Ago2 was
immunoprecipitated with the preblocked beads for 4 h at 4°C.
The beads were washed once with wash buffer and twice in wash
buffer containing 650mMNaCl, transferring the slurry to a fresh
tube on the last wash, and bound RNA was extracted with
TRIzol. For RT-QPCR, the samples were treated with DNase I
(amplification grade; Invitrogen), reverse-transcribed with gene-
specific reverse primers (MessageSensor RT; Ambion), and
amplified by using SYBR Green PCR Master mix (Applied
Biosystems). Six replicate experiments (both total RNA and
immunoprecipitated RNA), along with reference RNA, were
amplified by using the MessageAmp II aRNA kit (Ambion) with
direct incorporation of Cy3- and Cy5-labeled UTP. Samples
were hybridized to Agilent Whole Human Genome 4  44K
chips.
Overexpression and Depletion of miR-124a in MEFs and Cortical
Neurons. For overexpression of miR-124a, MEFs were plated at
1 105 cells per 6-cm dish and transfected by calcium phosphate
precipitation as described in ref. 24. For depletion of miR-124a,
embryonic day 15.5 primary cortical neurons at 4 days in vitro
(DIV) were transfected with 500 nM 2O-methyl (2OMe)
oligoribonucleotides (IDT) using Lipofectamine 2000 (Invitro-
gen) following the manufacturer’s protocol. After the indicated
time, relative abundance of selected mRNAs was determined by
quantitative real-time PCR as described for cortical progenitors
using a relative standard curve generated from 10-fold serial
dilutions of MEF cDNA.
Luciferase Sensor Assays. 293S(Ago2), MEF, cortical neuron, or
TCMK1 cells were transfected with the firefly luciferase reporter
and pRL-TK plasmids and miR-124a, miR-124a 2-OMe inhib-
itors, or GFP siRNA. Luciferase activity was measured by using
the Dual Luciferase reporter system (Promega).
Detailed methods are presented in SI Materials and Methods.
Oligonucleotides used in the study are listed in SI Table 3.
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